What is a minimal clinically important difference for clinical trials in patients with disorders of consciousness? a novel probabilistic approach.
Over the last 30 years, there has been a growing trend in clinical trials towards assessing novel interventions not only against the benchmark of statistical significance, but also with respect to whether they lead to clinically meaningful changes for patients. In the context of Disorders of Conscio...
Saved in:
| Main Authors: | Martin M Monti, Norman M Spivak, Brian L Edlow, Yelena G Bodien |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0290290 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accounting for Withdrawal of Life-Sustaining Treatment in the Analysis of Traumatic Brain Injury Studies
by: Brian C. Healy, et al.
Published: (2025-01-01) -
Perspective: Minimal clinically important difference (MCID) and Alzheimer's disease clinical trials
by: Jeffrey Cummings
Published: (2025-01-01) -
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
by: J. Scott Andrews, et al.
Published: (2019-01-01) -
Climate-Conscious Glaucoma Care: Strategies to Minimize the Environmental Impact in the Operating Room and in the Clinic
by: Samantha R. Goldburg, et al.
Published: (2025-01-01) -
Minimal Clinically Important Difference in Parkinson’s Disease as Assessed in Pivotal Trials of Pramipexole Extended Release
by: Robert A. Hauser, et al.
Published: (2014-01-01)